行情

RMD

RMD

瑞思迈
NYSE

实时行情|Nasdaq Last Sale

175.36
-1.26
-0.71%
交易中 15:20 02/20 EST
开盘
176.65
昨收
176.62
最高
176.65
最低
172.52
成交量
14.62万
成交额
--
52周最高
177.99
52周最低
96.81
市值
253.60亿
市盈率(TTM)
55.25
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

RMD 新闻

  • Add These 5 GARP Stocks to Your Portfolio for Maximum Returns
  • Zacks.5小时前
  • Bruker (BRKR) Stock Rises on Strong Preliminary Q4 Show
  • Zacks.5小时前
  • The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
  • Benzinga.8小时前
  • FDA Says ResMed Recalls Stellar 100 And 150 Non-invasive And Invasive Ventilators Due To Sound Alarm Failure; FDA Says Has Identified ResMed's Recall As Class 1 Recall
  • Reuters.1天前

更多

所属板块

先进医疗设备和技术
-1.06%
医疗设备和用品
-0.81%

热门股票

名称
价格
涨跌幅

RMD 简况

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
展开

Webull提供ResMed Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。